SCHEMBL22019707

SCHEMBL22019707

Cc1c(C2CCC2)nc2c(c1C)CCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
HRH2 P25021 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ACHE P22303 7/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
BPTF Q12830 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
CRHR1 P34998 1/20 0.34
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33
CDC7 O00311 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
ALDH1A1 P00352 2/20 0.32
BCHE P06276 5/20 0.31
GRIN1 Q05586 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22019706 0.94 KDM4E (0.38) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL22021184 0.84 ACHE (0.48) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL30162424 0.84 ACHE (0.48) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL24871633 0.82 KDM4E (0.33) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL24978542 0.82 CRHR1 (0.33) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL22020067 0.80 KDM4E (0.36) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL30120755 0.79 ACHE (0.50) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL22010279 0.79 ACHE (0.50) KDM4EHRH2HRH3ACHEMEN1
SCHEMBL24871951 0.76 KDM4E (0.33) KDM4EACHEMEN1MAPK1KMT2A
SCHEMBL24871638 0.76 KDM4E (0.33) KDM4EACHEMEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154499-A1 SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 WO disclosed
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed